3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
12
Terminated
7
Active not recruiting
3
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Recurrence
4
Immunoglobulin Light-chain Amyloidosis
4
Neoplasms, Plasma Cell
3
Hematologic Neoplasms
3
Renal Insufficiency
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Thalassemia
1
Plasmablastic Lymphoma
1
Peripheral Nervous System Diseases
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Burkitt Lymphoma
1
Anemia, Sickle Cell
1
Amyloidosis
1
Acute-Phase Reaction
1
Interventions
Blood Specimen Collection
38
pembrolizumab
36
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
18
Exercise
17
Carboplatin
16
Nivolumab
15
atezolizumab
14
Cisplatin
14
Drug Therapy
13
Paclitaxel
12
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
12
Trastuzumab
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Pemetrexed
9
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Bortezomib
×
Clear all
NCT07025005
2025-11-04
VRd MM Fibrate
Tanta University
Phase 4
Recruiting
44 enrolled